glp 1 health risks The promise and peril of GLP-1 agonists: What we do (and don't) know as of August 2024 America's Poison Centers - GLP-1

Today, there is still a large number of GLP-1R agonists entering clinical trials, which will lead to a big explosion in the future, so let's wait and see together

Claims may be stronger when the injury resulted in long-term impairment, surgical procedures, significant financial losses, or permanent health limitations

It seems like an easy swap for those who dont love the idea of injecting themselves with a needle but there are a few catches

Scientific References GLP-1 receptor agonists: reports of diabetic ketoacidosis when concomitant insulin was rapidly reduced or discontinued

No medical recommendations were made

At 72 weeks, 42.7% of GLP-1 receptor agonist users lost any amount of weight, and 10.5% lost 10% or more of their body weight